Sophia E. Shanko, PhD

Founder and CEO at ShanX Medtech BV
  • Claim this Profile
Contact Information
us****@****om
(386) 825-5501
Location
Eindhoven, North Brabant, Netherlands, NL
Languages
  • Albanian Native or bilingual proficiency
  • Greek Native or bilingual proficiency
  • English Full professional proficiency

Topline Score

Topline score feature will be out soon.

Bio

Generated by
Topline AI

You need to have a working account to view this content.
Join now
You need to have a working account to view this content.
Join now

Credentials

  • Certificate of Appreciation
    Institute of Electrical and Electronics Engineers
    Nov, 2013
    - Nov, 2024
  • Certificate of Appreciation
    World Scientific and Engineering Academy and Society (WSEAS)
    Jul, 2013
    - Nov, 2024

Experience

  • ShanX Medtech BV
    • Netherlands
    • Medical Equipment Manufacturing
    • 1 - 100 Employee
    • Founder and CEO
      • Apr 2019 - Present

      The establishment of ShanX Medtech BV is an achievement of enterpreneurship combined with technological innovation. My role is to start it all up from an idea to an end product and to the final step of advancing the impact on global social development. The establishment of ShanX Medtech BV is an achievement of enterpreneurship combined with technological innovation. My role is to start it all up from an idea to an end product and to the final step of advancing the impact on global social development.

  • Eindhoven University of Technology
    • Netherlands
    • Research Services
    • 700 & Above Employee
    • PhD Candidate
      • Nov 2016 - May 2021

      The coronavirus perfectly highlights the need of fast diagnostic tools that can be used at the point-of-care to enable fast decision making. Within these tools a drop of patient sample (i.e. blood) can be loaded where a target (like an antibody) can be found. A detection molecule (biosensor) is added that can detect the target, bind to it and change color. To ensure quick results, these tools can be further optimized. Instead of simply waiting for the biosensor to randomly encounter the antibody, their chances of meeting and binding can increase by introducing kinetics within the sample thereby mixing the contents of the chip. In our work at Microsystems, we show that this enhancement can be realized by adding magnetic particles to the sample, which are moved in a controlled manner to induce mixing. We test our approach with a biosensor that detects HIV antibodies. In specific biosensor-antibody conditions we can see a clear difference in time-to-result between mixing and non-mixing scenarios. Using such an approach in a point-of-care device we can halve the time of obtaining results clearly highlighting the benefits of mixing. In this way, the time needed to provide a diagnosis is decreased and fast decision making is enabled. Show less

  • GE HealthCare
    • United States
    • Hospitals and Health Care
    • 700 & Above Employee
    • Software Engineer (Summer Intern)
      • Jun 2015 - Aug 2015

      Creating interface for automated measurement process of application-specific integrated circuit (ASICs) on transducer probes. Creating interface for automated measurement process of application-specific integrated circuit (ASICs) on transducer probes.

Education

  • Eindhoven University of Technology
    Doctor of Philosophy - PhD, Microsystems for high precision diagnostics
    2016 - 2020
  • Heriot-Watt University
    Master’s Degree, Smart Systems Integration MSc (Microelectromechanical systems)
    2014 - 2016
  • Piraeus University of Applied Sciences
    Bachelor's Degree, Electrical engineering- Robotics
    2008 - 2013
  • 19th Secondary School of Athens
    High School
    2004 - 2008
  • Budapest University of Technology and Economics
    MEMS
  • Høgskolen i Buskerud og Vestfold (HBV)
    MSc, Microelectromechanical Systems

Community

You need to have a working account to view this content. Click here to join now